Orlando 407-337-3000
Hablamos tu Idioma
The Villages 352-441-2000

Study

Alzheimer’s Cortisol Study

Just one pill a day.

A New Approach To Fighting Alzheimer's

Charter Research is seeking volunteers in a new clinical trial of Xanamem, an oral medication designed to treat individuals with mild or moderate dementia due to Alzheimer’s. Xanamem was developed in response to evidence of a strong association between chronically-raised cortisol levels and the development of cognitive impairment in Alzheimer’s disease. The drug is designed to target and block production of cortisol inside brain neurons.

One study of Xanamem demonstrated that healthy, elderly individuals with higher cortisol levels were significantly more likely to develop Alzheimer’s disease than those with lower cortisol levels. The study authors concluded that therapies aimed at lowering cortisol levels should be considered as a potential way of addressing the development of Alzheimer’s disease.

 

Who is eligible?

You may qualify for this study if:

  • You are at least 50 years old.
  • You have mild or moderate dementia, likely to be due to Alzheimer's, in the opinion of the Principal Investigator.
  • You have a reliable study partner.

Sign Up

Schedule Your Assessment

Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.

Get More Information

Your contact information

This field is hidden when viewing the form

Do you live in Central Florida?

This field is hidden when viewing the form

Preferred Charter Research location

I would like to receive the Charter Research newsletter.

Comments (optional)

I agree to receive text messages from Charter Research for scheduling purposes.*

Untitled(Required)
This field is hidden when viewing the form

*By checking this box, I agree to receive SMS from Charter Research. The SMS frequency may vary. Data rates may apply. Reply STOP to opt-out of receiving SMS messages. If you need HELP with appointments or scheduling, please call 407-337-3000.
This field is for validation purposes and should be left unchanged.

Locations supporting this study

Select Location: